Between 2013 and 2019, cardiovascular system medicine use in Australia generally trended downward, with annual decreases varying between -0.28% and -2.01%. However, starting in 2020, there was a notable shift with consistent year-on-year increases, rising from 3.26% in 2020 to 1.88% in 2023. As of 2023, usage stood at 411.9 units, measured as Defined Daily Dosage per thousand persons per day. Looking forward, the forecast indicates a continued but slower growth trend, with a projected 5-year CAGR of 0.68% leading to an anticipated usage of 432.2 units by 2028.

Future trends to watch for include:

Potential impacts of new medical guidelines or breakthroughs in cardiovascular treatments.
Influence of public health initiatives focused on heart health and lifestyle changes.
Demographic shifts, particularly as the population ages, which may drive higher demand for cardiovascular medications.